VITA Group have been hurt by rumours of a Telstra buy back of its high performing stores which sent its share price sharply downwards.
ERM Power took a 226 per cent hit to its profits although it has forecast a return to solid margins.
And both Impedimed and Capilano Honey have been spending money on research and development, with the end game for each likely to see a turnaround in their performances.
CLICK BELOW FOR THIS YEAR'S TOP 50
Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support